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Abstract 
Background: Non-invasive assessment of stroke volume (SV), cardiac output (CO) and cardiac 
index (CI) has shown to be useful for the evaluation, diagnosis and/or management of different 
clinical conditions. Through pulse contour analysis (PCA) cuff‑ based oscillometric devices would 
enable obtaining ambulatory operator-independent non-invasive hemodynamic monitoring. There are 
no reference intervals (RIs), when considered as a continuum in childhood, adolescence and adult 
life, for PCA-derived SV [SV(PCA)], CO [CO(PCA)] and CI [CI(PCA)]. The aim of the study were 
to analyze the associations of SV(PCA), CO(PCA) and CI(PCA) with demographic, anthropometric, 
cardiovascular risk factors (CVRFs) and hemodynamic parameters, and to define RIs and percentile 
curves for SV(PCA), CO(PCA) and CI(PCA), considering the variables that should be considered 
when expressing them.  
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Methods: In 1449 healthy subjects (3–88 years) SV(PCA), CO(PCA) and CI(PCA) were non-
invasively obtained (Mobil-O-Graph; Germany). Analysis: associations between subject 
characteristics and SV(PCA), CO(PCA) and CI(PCA) levels (correlations; regression models); RIs 
and percentiles for SV(PCA), CO(PCA) and CI(PCA) (parametric methods; fractional polynomials).  
Results: Sex, age, and heart rate would be explanatory variables for SV, CO, and CI levels. SV 
levels were also examined by body height, while body surface area (BSA) contributing to evaluation 
of  CO and CI. CVRFs exposure did not contribute to independently explain  the values of the 
dependent variables. SV, CO and CI levels were partially explained by the oscillometric-derived 
signal quality. RIs and percentiles were defined.  
Conclusions: Reference intervals and percentile for SV(PCA), CO(PCA) and CI(PCA), were 
defined for subjects from 3–88 years of age, results are expressed according to sex, age, heart rate, 
body height and/or BSA. 
Key words: adolescents, adults, cardiac output, children, pulse contour analysis, reference 
intervals 
 
 
Introduction 
Non-invasive assessment of left ventricle (LV) stroke volume (SV), cardiac output (CO) and 
cardiac index (CI) were shown to be useful for the evaluation, diagnosis and/or management of 
different clinical and physiological conditions in both pediatric, and adult populations [1, 2]. Several 
non-invasive and/or minimally invasive approaches have been proposed to determine SV, CO and CI 
(i.e. transpulmonary-thermodilution, thoracic bioimpedance-bioreactance, ultrasonography). Among 
them, echocardiography stands out as a method widely used and recommended in clinical practice 
[3–5]. However, different factors contribute to circumscribe the use of echocardiography to certain 
contexts and conditions, limiting its widespread use (i.e. for community-based epidemiological 
studies). Among those factors are: (1) physical (size) restrictions and cost of the devices, (2) 
operator-dependency and the need for a learning-curve, (3) inability to obtain adequate records in 
many subjects or conditions, (4) different acquisition approaches may affect measurement 
variability, (5) a relatively long period of time is required to complete a study and/or (6) ambulatory 
records or continuous monitoring of the variables cannot be obtained [6, 7]. Pulse contour analysis 
(PCA) of blood pressure (BP) waveforms obtained non-invasively would enable estimating the SV, 
CO and CI [8–12]. Among the different approaches and devices available, the cuff‑ based 
oscillometric devices would be of choice, in cases of population studies within a community, taking 
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into account their portability, high speed of measurement (2–3 min), operator-independence and 
need for minimal collaboration of the subject (e.g. children) [13–15]. 
In both, pediatric and adult populations, there is scarce data about normal and reference 
values for SV, CO and CI at rest. That is particularly true for data obtained from PCA. Furthermore, 
available information acquired in specific (i.e. Asian) populations cannot not be extrapolated to other 
populations [16, 17]. The present group of researchers have been working on the identification and 
definition of particular characteristics (i.e. age-related changes, percentile curves, reference intervals 
[RIs]) of cardiovascular variables in several populations; with special emphasis which considers 
childhood, adolescence and/or adult life as a continuum [18–23]. 
The main aims herein, were to analyze the associations of SV(PCA), CO(PCA) and CI(PCA) 
with demographic, anthropometric, cardiovascular risk factors (CVRFs) and hemodynamic 
parameters, and to define percentile curves and RIs for SV(PCA), CO(PCA) and CI(PCA), taking 
into account the variables that should be considered when expressing them (e.g. age, sex, body 
surface area [BSA]). 
 
Methods 
Healthy subjects (n = 1449; 3–88 years) from the community were considered for enrolment 
(Table 1) [18–22]. Hypertension, diabetes or dyslipidemia were considered present if the subject 
reported being in treatment and/or a previous diagnosis of their condition. Subjects were classified as 
sedentary when the physical activity they performed was lower than a moderate intensity of physical 
load. Smoking at least one cigarette per week was defined as a current smoker.  Family history of 
cardiovascular disease was defined by the presence of first-degree relatives with premature 
cardiovascular disease [18–22]. Body mass index (BMI) was calculated as the weight-to-squared 
height ratio converted into percentiles/z-scores (subjects < 18 years) [18–22]. 
 
Pulse contour analysis 
Readings were obtained after 10 min of rest. The oscillometric-cuff (Mobil-O-Graph; I.E.M.-
GmbH, Germany) was placed on the left arm. The device measured peripheral (brachial) mean BP 
(MBP) and determined peripheral systolic BP, diastolic BP and pulse pressure (pSBP, pDBP, pPP). 
Peripheral waveforms were calibrated to pDBP and calculated MBP (MBP = pDBP + pPP/3). From 
the peripheral measurements, the Mobil-O-Graph determined the central (aortic) BP waveform and 
quantified [14, 15]: (1) central systolic BP, diastolic BP and pulse pressure (cSBP, cDBP, cPP); (2) 
heart rate (HR); (3) pulse wave analysis (PWA)-derived parameters like P1 and P2, augmented 
pressure (AP), augmentation index without and with normalization to a HR = 75 beats/minute (AIx, 
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AIx@75), pulse wave velocity (PWV), forward (Pf) and backward (Pb) wave components, reflection 
coefficient; (4) SV, CO, CI, and total systemic vascular resistance. Only data from accurate waves 
were considered. Record quality was consigned as an in-device quality index: (1 — excellent, 2 — 
good, and 3 — minimally acceptable record). Data assigned to each subject were an average of at 
least three measurements. 
 
Data analysis 
Data analysis was done using MedCalc (v.18.5, MedCalc Inc., Belgium) and IBM-SPSS 
Statistical Software (v.20, SPSS Inc., USA). A p < 0.05 was considered statistically significant. 
Associations between the subject characteristics (demographic, anthropometric, CVRFs, 
hemodynamic characteristics) and the SV(PCA), CO(PCA), CI(PCA) and signal-quality index levels 
were evaluated. To this end, simple and point-biserial correlations (Table 2) and multiple linear 
regression models (MLR, Stepwise) were considered (Table 3). After age, sex, BSA and height 
adjustment, there were no significant associations between the exposure to CVRFs and SV, CO or CI 
levels. Consequently, disregarding their exposure to CVRFs, all  subjects studied could be 
considered in constructing the RIs.  
As a result of the analysis described: (1) sex and age-specific RIs for SV(PCA), CO(PCA) 
and CI(PCA); (2) height specific RIs for SV(PCA) and (3) BSA specific RIs for CO and CI were 
considered necessary (Table 3). Then, age-related, height-related and BSA-related (always 
discriminated by sex) equations for mean and SD values were obtained for PCA-derived parameters. 
To this end, parametric regression methods based on fractional polynomials (FPs) were implemented 
[18–21, 24–27]. Briefly (as an example), mean and SD regression curves for age-specific SV(PCA), 
CO(PCA) and CI(PCA) were defined as fitting FPs. Thereafter, age-specific mean and SD values 
could be obtained. As an example, CO(PCA) mean equation would be: = a + b × agep + c × ageq 
+…, where a, b, and c, are coefficients, and p, q, are powers, with numbers selected from the set [-2,-
1,-0.5, 0, 0.5, 1, 2, 3], estimated from the regression for the mean CO(PCA) curve. Continuing the 
example, FPs with powers [1, 2], that is, with p = 1 and q = 2, illustrates an equation with the form a 
+ b × age + c × age2 [24]. Residuals were used to assess the model fit, deemed appropriate if the 
scores were normally distributed, with a mean equal to 0 and an SD equal to 1, randomly scattered 
above and below 0 when plotted against age. The best fitted curves, considering visual and 
mathematical criteria (Kurtosis and Skewness coefficients) were selected. From the mean and SD 
equations, and considering the standard normal distribution (Z) age-specific, HR-specific, height-
specific and BSA-specific percentiles were defined (SV(PCA): Fig. 1; Suppl. Tables S1–S6; 
CO(PCA): Fig. 2; Suppl. Tables S7–S12; CI(PCA): Fig. 3; Suppl. Tables S13–S18). The 1th, 2.5th, 
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5th, 10th, 25th, 50th, 75th, 90th, 95th, 97.5th, and 99th percentile curves were calculated as mean + Zp × 
SD, where Zp assumed –2.3263, –1.9599, –1.6448, –1.2815, –0.6755, 0, 0.6755, 1.2815, 1.6448, 
1.9599, and 2.3263 values, respectively. 
The minimum sample size required (n = 377 subjects) for RIs construction (i.e. for males or 
females) was defined considering a normal distribution for the covariate in the sample 
(conservatively ), a 95% and 90% limit of reference and confidence interval (two-sided), 
respectively; with a 95% and 10% reference range and relative margin of error, respectively [18–21, 
28]. According to the central limit theorem, a normal distribution was assumed considering Kurtosis 
and Skewness coefficients distribution and the number of subjects studied (sample size  30) [29]. 
 
Results 
SV(PCA), CO(PCA), CI(PCA): Impact of sex, age, HR and anthropometric characteristics 
Table 1 describes characteristics of the 1449 subjects included in the study. Note the wide age 
range considered (3–88 years old) and the balanced sex distribution (male = 51.4%). 
Table 3 shows explanatory variables for SV(PCA), CO(PCA) and CI(PCA) values (MLR models). 
The variables considered were those with statistically significant associations with PCA-derived data 
in bivariate analyses (Table 2). Sex, age, and HR would be explanatory variables for dependent 
variables (SV, CO, CI). SV levels were also explained by height, while BSA contributed to explain 
CO and CI. CVRFs did not contribute to explain, independently, the values of the dependent 
variables. Then, data from all the studied subjects could be considered for the RIs, which should be 
sex-specific and expressed taking into account age, HR and height or BSA) (Table 3). It is 
noteworthy that variations in SV, CO and CI were partially explained by the oscillometric-derived 
signal quality. A higher signal quality was associated with higher SV, CO and CI (Tables 2, 3). 
 
 
SV(PCA), CO(PCA), CI(PCA): Percentile curves and RIs for children, adolescents and adults 
Figure 1 shows age, HR and height-specific percentile curves for SV(PCA). Supplementary 
Tables S1–S6 show sex-specific RIs for SV considering age, HR and height. 
Age, HR and BSA-specific percentile curves for CO(PCA) and CI(PCA) in males and 
females are shown in Figures 2, 3. Supplementary Tables S7–S12 show sex-specific RIs for CO 
considering age, HR and BSA. Supplementary Tables S13–S18 show sex-specific RIs for CI 
considering age, HR and BSA. 
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Discussion 
The work’s main findings were: 
— First, in the construction of RIs for PCA-derived SV, CO and CI, not only were the age and 
anthropometric variables of the subjects taken into account, but also their sex and HR. The 
importance of the different explanatory variables varied depending on the parameter for 
which the RIs were constructed (SV, CO or CI) (Tables 2, 3). 
— Second, this study represents the first study in which RIs and percentiles for PCA-derived 
SV, CO and CI are defined for children, adolescents, adults and elderly subjects (as a 
continuum throughout life; 3–88 years old) (Figs. 1–3; Suppl. Tables S1–S18). 
— Third, when SV levels were analyzed it a steep rise in SV was observed during the first two 
decades, followed by a slow decline over the rest of their lives; additionally, the higher the 
HR, the lower the SV, while the higher the height, the higher the expected SV values (Fig. 1). 
There was a rapid increase in CO in the first two decades of life, followed by a fall 
throughout adult life (Fig. 2). Initially CO increases as HR increases, until HR reaches ~70-
80 beats/minute, then CO begins to fall in association with increases in HR; additionally, CO 
increases as the BSA increases (Fig. 2). CI values showed an important fall during the first 
two decades and then they remained practically unchanged over the rest of their lives (Fig. 3). 
CI increases in association with increases in HR, while lower CI values were observed in 
association with higher BSA values (Fig. 3). 
The need to express SV, CO and/or CI values considering the age and/or anthropometric 
characteristics is widely known and accepted. However, it is of note that RIs constructed for a 
population including subjects from childhood to old age are scarce; in most works the age-groups 
included people of very different ages (i.e. 20 years apart) [30]; only adults were considered [5, 30, 
31]; subjects aged 60–65 and older were assigned to a single group [5, 30] and/or non-uniform age 
ranges were considered (i.e. 0–2.9, 3–5.9, 6–11.9, 12–17.9, 18–29.9, 30–59.9, and ≥ 60 years old) 
[32]. The above does not allow for an adequate analysis of the age impact on hemodynamic 
characteristic and their variations. In addition, it does not allow for the use of accurate cut-off points 
in clinical practice (i.e. a 31 year old would be given reference values for a group ranging from 30 to 
50.9 years old) [32]. 
The need to define RIs for males and females separately is not universally accepted and could 
even be considered controversial. There are works in which it was considered necessary to define 
sex-specific RIs, others in which the issue was not analyzed or was evaluated inaccurately, and 
finally, there are works that considered negligible the sex-related differences in the RIs of 
hemodynamic variables [16, 32–34]. In relation to the latter, sex-specific RIs were not defined; even 
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when sex-related differences in hemodynamic parameters remained statistically significant after 
controlling for anthropometric parameters [32]. Results herein, reinforce that the RIs in males  differ 
for females, even after adjusting for height, weight and/or BSA (Table 3); highlighting the need for 
sex-specific RIs. 
Finally, it is of note that oscillometric-derived signal quality was associated with SV, CO and CI 
values (Table 3). On average, a variation in the signal quality equal to the unit, could independently 
explain variations in SV, CO and CI equal to 2.8 mL/beat, 0.38 L/min and 0.13 L/min/m2, 
respectively. Therefore, at least in theory, further work would be necessary to identify the specific 
wave characteristics required and/or the minimum quality value of an aortic waveform that would 
allow accurate CO values to be obtained using PCA. 
Related with our second and third main result, when RIs for SV were analyzed taking into 
account age-related variations, a steep rise in SV was observed during the first two decades, followed 
by a slow decline during the rest of life (Fig. 1). In addition, the higher the HR, the lower the SV, 
while the greater the height, the higher the expected SV (Fig. 1). According to available research, 
until now there have been no reference values defined based on simultaneous or joint analysis of 
children, adolescents, adults or elderly subjects from a population. Since most available data 
correspond to values for pediatric or adult subjects it was not possible to perform direct comparisons 
with the present data. Therefore, a comparative analysis, from available works, an average was taken 
and SD values were obtained for the different ages. Then, assuming normal distribution, the 97.5th 
(mean +1.96 SD), 50th (mean) and 2.5th (mean –1.96 SD) percentiles were calculated (Figs. 4, 5). 
Being aware of the described limitation, it could be said that similar trends were observed among 
other studies. 
Cattermole et al. [32] in a population based, cross-sectional, observational study performed in 
healthy Chinese subjects (n = 2218, age mean/range: 16.4/0.5–89 years old, 52% females), including 
data previously published by Ho et al. in 2013 (n = 590, age: 12–18 years old, 49% boys) and Chan 
et al. in 2014 (n = 165, age groups: 61–70, 71–80,  80 years old, 48.5% males), reported reference 
ranges for SV, CO and CI data obtained non-invasively (transcutaneous continuous Doppler) [32–
34]. Despite methodological differences, including the non-uniformity of ranges used in the 
determination of age-subgroups and the lack of consideration of sex-related differences, in 
agreement with the present study the authors found a rapid increase in SV reaching its peak in their 
20s followed by a slow fall from the beginning of the third decade of life (Fig. 4). Time profiles and 
percentiles 2.5th, 50th and 97.5th reported by Cattermole et al. [32] are similar to those presented here. 
Cattermole et al. [32] is almost the only study that can be fully compared with the present results 
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(i.e. it included a large number of subjects within a wide age range). However, they studied: (1) a 
small number of subjects (e.g. n = 96 [31, 35]), (2) considered few age-groups and/or wide age 
intervals in the same group (i.e. 20–40, 40–60, ≥ 60) [30], (3) defined sex-specific analysis as 
unnecessary despite the sex-related differences observed [16] and/or (4) included subjects with mild 
chronic illness [34], also evidenced an SV tendency which decreases with age, within the 
heterogeneity of the reported values. The tendency of SV (percentile 50th) to decrease with age was 
evidenced regardless of the measurement method used: 3D-echocardiography [30], PCA [16], 
magnetic resonance [31, 35], transcutaneous continuous-wave Doppler [32–34], biplane-
echocardiography (Fig. 4) [5]. The rates of SV change with age (slope of association between SV 
50th-percentile and age) were not very different when compared to results of other authors among 
themselves to the present data. 
The analysis of age-related RIs for CO showed there was a rapid increase in CO levels over the 
first two decades of life, followed by a fall throughout adult life (in both, males and females) (Fig. 
2). Initially CO increases as HR increases, until HR reaches ~70–80 beats/minute, then CO begins to 
fall in association with increases in HR; CO increases as the BSA increases (Fig. 2). 
Temporal profiles for CO were similar to those reported by Cattermole et al. (2017) [32]. The 
authors found an increase in CO, until 20 years of age. Thereafter, an age-related reduction in CO 
was observed. Cattermole et al. values for the 50th-percentile and those from  the present work 
almost overlap. In turn, Solanki et al. [16] and Chan et al. [34] reported average values (50th-
percentile) for CO in adults and old age subjects similar to those found in the current data (Fig. 5). 
Cardiac index values showed an important fall during the first two decades and then they 
remained practically unchanged (Fig. 3). CI values were associated with HR and BSA. CI increases 
in association with increases in HR, while lower CI values were observed in association with higher 
BSA values (Fig. 3). The described findings are in agreement with those reported by other authors 
(Fig. 5). In this regard, Cattermole et al. (2017) [32] and Ho et al. (2013) [33] described age-
associated variations in CI, and their 50th-percentile curves were similar to the present ones. The 
present curves and those reported by Solanki et al. (2018) [16] and Chan et al. (2014) [34] for the 
50th-percentile in adults are comparable. 
Jointly analyzing the described results, it could be stated that CO rises steadily and reaches a 
peak in the 15–20 (teenage) years of life. Thereafter, it gradually declines. However, when 
considering CO adjusted for BSA (that it is to say CI), maximum (peak) would be observed < 6 
years old, corresponding to a weight of 10–15 kg [32]. The variations in CO and CI could be related 
to and explained by the oxygen requirements of the tissues during those periods of life (i.e. those of 
maximum growth).  High absolute CO levels in teenagers probably corresponds to accelerated 
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growth and elevated oxygen consumption. From late teens onwards there is little or no growth, but a 
steadily declining level of physical activity was observed [32]. Overall, SV rises steadily until late 
teens then tends to decline gradually over the years, but when viewed against height (present data) or 
weight (Cattermole et al. data) [32], it shows a more linear positive relationship (Figs. 1, 4). 
 
Conclusions 
Sex, age, HR, and body height (for SV) or BSA (for CO and CI) are independent factors that 
explain PCA-derived hemodynamic values. Consequently, when constructing RIs of SV, CO and CI, 
it is necessary to discriminate using these variables. 
This study provides the largest database concerning RIs and percentile curves of LV 
SV(PCA), CO(PCA) and CI(PCA), obtained in children, adolescents and adults (3–88 years of age) 
from Latin-America (Uruguay), expressing results according to sex (males and females), age (year-
to-year), HR (beats/minute), body height (in cm) and BSA (m2). 
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Figure 4. Age-specific percentiles (97.5th, 50th and 2.5th) of left ventricular stroke volume obtained 
in the present population and those reported from other authors [5, 16, 30, 31, 32, 33, 34, 35]. 
 
Figure 5. Age-specific percentiles (97.5th, 50th and 2.5th) of left ventricular cardiac output and 
cardiac index obtained in the present population and those reported from other authors [16, 32, 33, 
34]. 
Table 1. Subjects characteristics                                     
    Entire group (n=1449) Male (n=745) Female (n=704) 
    MV SE SD Min. p25th p50th p75th Max. Range MV SE SD Min. p25th p50th p75th Max. Range MV SE SD Min. p25th p50th p75th Max. Range 
Sex (Male) [%] 51.4%   Mean 
Age [years] 29.3 0.7 22.4 3.9 12.4 18.3 50.1 88.8 84.9 28.9 0.9 21.3 4.2 12.4 18.3 49.0 84.4 80.2 29.6 1.0 23.4 3.9 12.5 18.3 53.3 88.8 84.9 
Body Weight [Kg.] 61.6 0.7 22.8 13.2 48.9 61.9 76.5 134.7 121.5 67.1 1.0 24.2 14.3 53.0 69.0 82.7 134.7 120.4 56.1 0.8 19.9 13.2 46.4 57.0 67.1 115.0 101.8 
Body Height [cm] 157.0 0.6 20.1 97.0 149.0 162.0 171.0 197.0 100.0 1.6 0.0 0.2 1.1 1.5 1.7 1.8 2.0 0.9 1.5 0.0 0.2 1.0 1.5 1.6 1.6 1.8 0.9 
Body Surface Area [m2] 1.61 0.01 0.39 0.59 1.43 1.66 1.87 2.65 2.06 1.71 0.02 0.41 0.67 1.51 1.80 1.99 2.65 1.98 1.50 0.01 0.34 0.59 1.41 1.58 1.70 2.23 1.63 
Body Mass Index [Kg./m2] 24.0 0.2 5.6 11.5 20.1 23.4 27.2 48.2 36.7 24.4 0.2 5.5 11.5 20.6 24.1 27.7 45.5 34.0 23.6 0.2 5.7 12.9 19.8 22.8 26.7 48.2 35.3 
z-score Body Mass Index (*) [SD]  1.10 0.08 1.93 -3.81 -0.13 0.64 1.88 9.64 13.45 1.32 0.12 2.15 -3.81 0.00 0.76 2.24 9.64 13.45 0.88 0.09 1.67 -3.00 -0.22 0.56 1.75 8.16 11.16 
Sedentarism [%] 44.2% 46.0% 55.6% 
Hypertension [%] 20.5% 21.5% 19.6% 
Current Smoke [%] 9.8% 11.2% 10.2% 
Dyslipidemia [%] 23.5% 24.6% 22.6% 
Diabetes [%] 3.2% 3.4% 3.1% 
Familiar History of premature atherosclerosis-related disorder [%] 10.8% 10.2% 12.4% 
Pharmacological Treatment for Hypertension [%] 15.9% 14.9% 16.9% 
Pharmacological Treatment for Dyslipidemia [%] 9.4% 12.2% 8.3% 
Pharmacological Treatment for Diabetes [%] 3.7% 4.1% 3.9% 
Total Cholesterol  [mg/dl] 205 2 43 99 175 201 231 363 264 200 3 44 99 170 195 227 363 264 211 3 42 120 184 205 240 336 216 
HDL Cholesterol  [mg/dl] 53 1 16 17 42 51 63 109 92 48 1 13 17 40 46 54 93 76 59 1 17 19 47 58 69 109 90 
LDL Cholesterol  [mg/dl] 126 2 40 31 97 120 148 293 262 126 3 42 31 97 120 148 293 262 126 3 38 49 98 120 149 244 195 
Triglycerides  [mg/dl] 130 5 88 1 76 105 150 742 741 136 7 89 34 80 112 163 742 708 123 6 85 1 72 101 141 538 537 
Glycaemia   95 1 20 64 86 93 100 296 232 95 1 14 65 88 94 101 172 107 95 2 25 64 85 91 99 296 232 
Signal Quality (continuous variable)   1.47 0.01 0.42 1.00 1.13 1.40 1.75 3.00 2.00 1.49 0.02 0.46 1.00 1.11 1.40 1.75 3.00 2.00 1.45 0.02 0.38 1.00 1.13 1.40 1.75 3.00 2.00 
Signal Quality (categorical variable)                                                       1 ("Excellent") [%] 61.3% 60.2% 62.4% 
2 ("Very good") [%] 36.9% 36.7% 37.1% 
3 ("Poor") [%] 1.8% 3.1% 0.5% 
pSBP [mmHg] 119 .402 14 85 110 118 126 199 114 120 .552 13 85 112 119 128 196 111 118 .581 14 86 108 115 125 199 113 
pMBP (Calculated; Form Factor: 0.33) [mmHg] 86 .329 11 54 79 85 93 148 94 87 .467 11 61 79 86 93 148 87 85 .462 11 54 78 84 91 140 86 
pDBP [mmHg] 70 .326 11 36 62 69 76 131 95 70 .478 11 41 62 69 77 131 90 70 .444 11 36 62 68 76 111 75 
pPP [mmHg] 49 .276 9 28 43 48 55 105 77 50 .400 10 28 43 49 56 105 77 48 .377 9 29 42 48 54 89 60 
Heart Rate (MOG) [beats/minute] 73 .410 14 33 62 71 81 135 102 70 .539 13 33 60 68 78 121 88 76 .595 14 41 66 74 84 135 94 
aSBP [mmHg] 108 .464 16 71 97 107 118 185 114 111 .670 16 77 101 110 121 180 103 105 .616 15 71 95 104 112 185 114 
aDBP [mmHg] 71 .326 11 38 63 70 78 133 95 72 .477 11 41 64 70 79 133 92 71 .444 11 38 63 70 77 112 74 
aPP [mmHg] 37 .332 11 15 30 35 42 88 73 40 .503 12 15 32 38 45 88 73 35 .409 10 15 28 33 39 82 67 
P1 [mmHg] 101 .394 13 67 92 100 109 162 95 105 .580 14 74 96 104 112 162 88 97 .486 12 67 89 96 104 151 84 
P2 [mmHg] 108 .464 16 71 97 107 118 185 114 111 .669 16 77 101 110 121 180 103 105 .616 15 71 95 104 112 185 114 
AP [mmHg] 8 .162 5 1 4 6 9 38 37 7 .220 5 1 3 5 9 37 36 8 .237 6 2 4 6 10 38 36 
Alx [%] 19 .320 11 -7 11 16 24 60 67 16 .415 10 2 9 13 21 53 51 22 .457 11 -7 14 19 28 60 67 
AIx@75 [%] 18 .342 12 -7 9 17 26 65 72 13 .422 10 -7 5 12 20 43 50 22 .463 11 -6 14 22 30 65 71 
Pb [mmHg] 15 .151 5 4 11 14 17 38 34 16 .229 5 4 12 15 18 38 34 14 .186 4 4 11 13 16 35 31 
Pf [mmHg] 24 .223 8 11 19 23 28 66 55 26 .348 8 11 21 25 30 66 55 23 .260 6 11 18 22 25 53 42 
RC [%] 60 .279 9 18 55 61 67 81 63 61 .388 9 18 55 61 67 81 63 60 .401 10 19 54 61 67 80 61 
PWV [m/s] 6 .060 2 4 5 5 7 15 12 6 .077 2 4 5 5 7 13 9 6 .092 2 4 5 5 7 15 12 
SV [ml/beat] 73 15.981 0 33 62 73 84 125 91 78 .646 15 40 67 80 88 125 85 67 .609 15 33 58 68 77 114 81 
CO [liters/minute] 5.09 0.02 0.74 3.10 4.54 5.06 5.63 7.10 4.00 5.28 0.03 0.74 3.40 4.73 5.28 5.82 7.10 3.70 4.91 0.03 0.70 3.10 4.43 4.86 5.40 6.68 3.58 
SVR [s.mmHg/ml] 1.12 0.01 0.19 0.75 0.98 1.11 1.25 1.98 1.23 1.10 0.01 0.19 0.75 0.96 1.08 1.23 1.98 1.23 1.15 0.01 0.19 0.78 1.02 1.15 1.28 1.95 1.17 
CI [l.min/m2] 3.32 0.90 0.03 1.53 2.68 3.15 3.70 6.77 5.23 3.26 0.04 0.93 1.53 2.60 3.03 3.73 6.77 5.23 3.37 0.04 0.86 1.88 2.80 3.23 3.68 6.67 4.78 
(*): calculated for subjects under 18 years old. SBP, DBP, PP, MBP: Systolic, Diastolic, Pulse and Mean Blood Pressure, respectively. Prefix "p" and "a": peripheral (Brachial artery) and central (Aortic). MOG: Mobil-O-Graph. P1 and P2: blood pressure at time 1 and 2, respectively. AP: Augmented pressure. 
AIx and AIx@HR75: augmentation index non-normalized and normalized considering a heart rate equal 75 beats/minute. Pb and Pf: backward and forward aortic blood pressure component amplitude, respectively. PWV: pulse wave velocity. RC: Reflection coefficient. CO: Cardiac output. SVR: Systemic 
vascular resistances. CI: cardiac index. HR: Heart rate. Min.: Minimal value. Max.: Maximal value. 
 
Table 2. Association (unadjusted and adjusted) between SV, CO or CI and demographic, anthropometric, cardiovascular risk factors exposition, hemodynamic and cardiovascular parameters 
                                            
    Bivariate (Unadjusted or Zero-order) Correlations  Bivariate (Adjusted) Correlations: Sex, Age, BMI and BSA 
Variable and Units 
SV (MOG) 
[ml/beat] 
CO (MOG) 
[liters/minute] 
CI (MOG) 
[l.min/m2] 
Signal Quality 
(continuous variable) 
Signal Quality 
(categorical variable) 
SV (MOG) 
[ml/minute] 
CO (MOG) 
[liters/minute] 
CI (MOG) 
[l.min/m2] 
Signal Quality 
(continuous variable) 
Signal Quality 
(categorical variable) 
    R p R p R p R p R p R p R p R p R p R p 
Sex [Female: 1; Male: 0] -.340 <0.001 -.246 <0.001 .060 .042 -.050 .092 -.046 .120 --- --- --- --- --- --- --- --- --- --- 
Age [years] .229 <0.001 -.096 .001 -.596 <0.001 .061 .039 .052 .081 --- --- --- --- --- --- --- --- --- --- 
Body Weight [Kg.] .503 <0.001 .329 <0.001 -.787 <0.001 -.044 .138 -.031 .302 -.236 <0.001 -.228 <0.001 .201 <0.001 .115 <0.001 .092 .002 
Body Height [cm] .635 <0.001 .407 <0.001 -.774 <0.001 -.126 <0.001 -.105 <0.001 .225 <0.001 .266 <0.001 -.177 <0.001 -.138 <0.001 -.114 <0.001 
Body Surface Area [m2] .584 <0.001 .377 <0.001 -.822 <0.001 -.081 .006 -.063 .032 --- --- --- --- --- --- --- --- --- --- 
Body Mass Index [Kg./m2] .276 <0.001 .215 <0.001 -.617 <0.001 .003 .909 .013 .661 --- --- --- --- --- --- --- --- --- --- 
z-score Body Mass Index (*) SD -.052 .186 .106 .007 -.050 .202 -.025 .524 -.036 .353 .000 .998 -.043 .270 -.243 <0.001 -.080 .041 -.108 .006 
Sedentarism [Yes: 1; No: 0] -.119 <0.001 .022 .477 -.038 .226 -.043 .176 -.032 .305 -.147 <0.001 .006 .857 .069 .029 -.043 .180 -.034 .282 
Hypertension [Yes: 1; No: 0] .067 .023 .043 .150 -.220 <0.001 .019 .511 .016 .589 -.017 .564 .101 .001 .081 .007 -.027 .369 -.025 .392 
Current Smoke [Yes: 1; No: 0] .090 .004 .002 .958 -.092 .003 .010 .736 .011 .724 -.006 .854 -.044 .156 .041 .183 .033 .293 .031 .323 
Dyslipidemia  [Yes: 1; No: 0] .033 .261 -.104 <0.001 -.321 <0.001 .088 .003 .076 .010 -.108 <0.001 -.086 .004 -.031 .304 .051 .085 .042 .156 
Diabetes [Yes: 1; No: 0] .006 .969 -.281 .055 -.471 .001 .182 .220 .246 .096 -.233 .133 -.463 .002 -.464 .002 .161 .303 .238 .124 
Family history of premature CVD [Yes: 1; No: 0] .070 .021 -.029 .340 -.152 <0.001 .040 .180 .038 .213 .030 .328 .013 .665 .007 .826 .025 .410 .025 .414 
Pharmacological Treatment for Hypertension [Yes: 1; No: 0] .013 .673 -.094 .002 -.258 <0.001 .108 <0.001 .081 .009 -.098 .002 .002 .950 .091 .003 .067 .032 .042 .178 
Pharmacological Treatment for Dyslipedemia [Yes: 1; No: 0] .032 .301 -.143 <0.001 -.288 <0.001 .144 <0.001 .122 <0.001 -.111 <0.001 -.136 <0.001 -.066 .035 .120 <0.001 .101 .001 
Pharmacological Treatment for Diabetes [Yes: 1; No: 0] -.048 .122 -.025 .418 -.149 <0.001 .031 .321 .017 .585 -.120 <0.001 -.012 .706 .013 .680 .005 .883 -.008 .805 
Total Cholesterol  [mg/dl] -.152 .003 -.205 <0.001 -.127 .013 .110 .030 .074 .146 -.164 .001 -.139 .007 -.096 .063 .091 .077 .057 .268 
HDL Cholesterol  [mg/dl] -.138 .008 -.184 <0.001 -.020 .699 -.038 .468 -.011 .825 .005 .930 .091 .084 -.054 .305 -.089 .091 -.043 .418 
LDL Cholesterol  [mg/dl] -.120 .024 -.156 .003 -.071 .185 .100 .060 .043 .416 -.137 .011 -.129 .016 -.085 .115 .078 .145 .024 .660 
Triglycerides  [mg/dl] -.009 .873 .012 .823 -.116 .031 .076 .156 .067 .210 -.099 .069 -.095 .082 -.020 .710 .084 .124 .070 .200 
Glycaemia  [mg/dl] -.069 .259 -.101 .100 -.204 .001 .056 .365 .061 .319 -.149 .016 -.108 .082 -.084 .177 .030 .624 .039 .536 
Signal Quality (continuous variable) .008 .784 -.296 <0.001 .007 .815 1.000 -----  .877 <0.001 .091 .002 -.272 <0.001 -.101 .001 ---- ---- .873 <0.001 
Signal Quality (categorical variable) .009 .751 -.269 <0.001 -.018 .543 .877 <0.001 1.00 -----  .078 .009 -.255 <0.001 -.125 <0.001 .873 <0.001 ---- ---- 
pSBP [mmHg] .252 <0.001 .267 <0.001 -.403 <0.001 -.025 .397 -.026 .371 -.013 .656 .208 <0.001 .087 .003 -.016 .581 -.023 .436 
pMBP (Calculated; Form Factor: 0.33) [mmHg] .187 <0.001 .138 <0.001 -.450 <0.001 .043 .149 .023 .432 -.108 <0.001 .108 <0.001 .051 .088 .050 .090 .024 .420 
pDBP [mmHg] .129 <0.001 .042 .159 -.430 <0.001 .084 .004 .052 .076 -.152 <0.001 .028 .351 .027 .367 .091 .002 .051 .084 
pPP [mmHg] .213 <0.001 .340 <0.001 -.080 .007 -.137 <0.001 -.101 .001 .131 <0.001 .241 <0.001 .088 .003 -.112 <0.001 -.082 .006 
Heart Rate [beats/minute] -.773 <0.001 -.015 .614 .547 <0.001 -.196 <0.001 -.187 <0.001 -.714 <0.001 .177 <0.001 .293 <0.001 -.270 <0.001 -.254 <0.001 
aSBP [mmHg] .520 <0.001 .192 <0.001 -.584 <0.001 .114 <0.001 .101 .001 .271 <0.001 .047 .117 -.066 .027 .186 <0.001 .160 <0.001 
aDBP [mmHg] .147 <0.001 .038 .200 -.430 <0.001 .110 <0.001 .071 .016 -.129 <0.001 .013 .666 .023 .446 .124 <0.001 .075 .012 
aPP [mmHg] .580 <0.001 .230 <0.001 -.392 <0.001 .050 .094 .070 .018 .423 <0.001 .042 .159 -.093 .002 .101 .001 .115 <0.001 
P1 [mmHg] .572 <0.001 .401 <0.001 -.496 <0.001 .038 .203 .029 .326 .299 <0.001 .272 <0.001 .103 .001 .099 .001 .075 .011 
P2 [mmHg] .520 <0.001 .192 <0.001 -.584 <0.001 .113 <0.001 .100 .001 .271 <0.001 .047 .118 -.066 .027 .185 <0.001 .159 <0.001 
AP [mmHg] .099 .001 -.422 <0.001 -.464 <0.001 .234 <0.001 .218 <0.001 .032 .289 -.467 <0.001 -.385 <0.001 .250 <0.001 .235 <0.001 
Alx [%] -.185 <0.001 -.625 <0.001 -.354 <0.001 .279 <0.001 .251 <0.001 -.207 <0.001 -.629 <0.001 -.436 <0.001 .298 <0.001 .272 <0.001 
AIx@75 [%] -.699 <0.001 -.601 <0.001 .057 .056 .136 <0.001 .113 <0.001 -.674 <0.001 -.451 <0.001 -.189 <0.001 .091 .002 .076 .011 
Pb [mmHg] .604 <0.001 .153 <0.001 -.456 <0.001 .126 <0.001 .131 <0.001 .456 <0.001 -.022 .468 -.135 <0.001 .179 <0.001 .176 <0.001 
Pf [mmHg] .519 <0.001 .234 <0.001 -.310 <0.001 .025 .406 .048 .102 .366 <0.001 .034 .255 -.083 .005 .077 .009 .094 .002 
RC [%] .369 <0.001 -.076 .011 -.447 <0.001 .244 <0.001 .214 <0.001 .302 <0.001 -.090 .002 -.140 <0.001 .276 <0.001 .241 <0.001 
PWV [m/s] .227 <0.001 -.116 <0.001 -.539 <0.001 .077 .009 .069 .020 .088 .003 -.056 .059 -.120 <0.001 .024 .411 .029 .336 
SVR [s.mmHg/ml] -.306 <0.001 -.715 <0.001 -.377 <0.001 .279 <0.001 .242 <0.001 -.425 <0.001 -.760 <0.001 -.500 <0.001 .269 <0.001 .235 <0.001 
CVD: atherosclerosis-related cardiovascular disease. Signal Quality: 1 (excellent), 2 (good), 3 (minimum acceptable). BMI: Body mass index. BSA: Body surface area. SBP, DBP, PP, MBP: Systolic, Diastolic, Pulse and Mean Blood Pressure, respectively. Prefix "p" and "a": peripheral (Brachial artery) 
and central (Aortic). P1 and P2: blood pressure at time 1 and 2, respectively. AP: Augmented pressure. AIx and AIx@HR75: augmentation index non-normalized and normalized considering a heart rate equal 75 beats/minute. Pb and Pf: backward and forward aortic blood pressure component 
amplitude, respectively. PWV: pulse wave velocity. RC: Reflection coefficient. SV: Stroke volume. CO: Cardiac output. SVR: Systemic vascular resistances. CI: cardiac index.  R: Pearson coefficient. *: for subjects <18 years. A p<0.05 (red text) was considered statistically significant. 
 
Table 3. Pulse contour analysis-derived stroke volume (SV), cardiac output (CO) and cardiac index (CI) data: explanatory variables (Multiple Linear Regression Models)           
                                
Dependent Variable Unit Model 
Unstandardized Coefficients Standardized Coefficients 
p 
95%-CI for β 
VIF R Adjusted R2 SE of the Estimate 
Change Statistics 
β SE β Lower Bound Upper Bound R2 Change p (F Change) 
Stroke volume [ml/beat] 1 
(Constant) 118.631 3.604   <0.001 111.528 125.734   
.627 0.390 9.817 0.393 8.336E-26 
Heart Rate [beats/minute] -.629 .053 -.627 <0.001 -.733 -.526 1.000 
Stroke volume [ml/beat] 2 
(Constant) 119.584 3.181   <0.001 113.315 125.854   
.728 0.526 8.659 0.136 6.848E-14 Heart Rate [beats/minute] -.577 .047 -.575 <0.001 -.669 -.485 1.020 
Sex [Female: 1; Male: 0] -9.384 1.172 -.374 <0.001 -11.694 -7.074 1.020 
Stroke volume [ml/beat] 3 
(Constant) 129.487 4.340   <0.001 120.933 138.041   
.743 0.546 8.473 0.021 0.001 
Heart Rate [beats/minute] -.654 .051 -.652 <0.001 -.755 -.552 1.288 
Sex [Female: 1; Male: 0] -8.651 1.169 -.344 <0.001 -10.955 -6.348 1.059 
Age [years] -.100 .031 -.167 0.001 -.160 -.040 1.278 
Stroke volume [ml/beat] 4 
(Constant) 94.483 10.338   <0.001 74.108 114.858   
.761 0.571 8.237 0.026 0.0002 
Heart Rate [beats/minute] -.622 .051 -.620 <0.001 -.722 -.521 1.327 
Sex [Female: 1; Male: 0] -5.941 1.351 -.236 <0.001 -8.604 -3.279 1.497 
Age [years] -.129 .031 -.216 <0.001 -.190 -.069 1.367 
Body Height [cm] 20.011 5.395 .207 <0.001 9.377 30.644 1.610 
Stroke volume [ml/beat] 5 
(Constant) 101.820 10.571   <0.001 80.984 122.655   
.769 0.582 8.127 0.013 0.008 
Heart Rate [beats/minute] -.654 .052 -.652 <0.001 -.755 -.552 1.406 
Sex [Female: 1; Male: 0] -5.980 1.333 -.238 <0.001 -8.607 -3.353 1.497 
Age [years] -.132 .030 -.221 <0.001 -.192 -.072 1.369 
Body Height [cm] 19.389 5.328 .200 <0.001 8.888 29.891 1.613 
Signal Quality (categorical variable) -2.806 1.063 -.118 0.009 -4.902 -.710 1.065 
Cardiac output [liters/minute] 1 
(Constant) 3.438 0.250   <0.001 2.945 3.931   
.401 0.157 0.681 0.160 4.923E-10 
Heart Rate [beats/minute] .024 .004 .401 <0.001 .017 .031 1.000 
Cardiac output [liters/minute] 2 
(Constant) 3.497 0.227   <0.001 3.050 3.944   
.559 0.306 0.618 0.151 3.940E-11 Heart Rate [beats/minute] .027 .003 .456 <0.001 .020 .034 1.020 
Sex [Female: 1; Male: 0] -0.582 0.084 -.393 <0.001 -0.747 -0.417 1.020 
Cardiac output [liters/minute] 3 
(Constant) 4.321 0.319   <0.001 3.693 4.950   
.592 0.341 0.602 0.038 0.0004 
Heart Rate [beats/minute] .023 .003 .392 <0.001 .016 .030 1.130 
Sex [Female: 1; Male: 0] -0.592 0.082 -.400 <0.001 -0.753 -0.432 1.021 
Signal Quality (categorical variable) -.380 .106 -.206 <0.001 -.588 -.171 1.114 
Cardiac output [liters/minute] 4 
(Constant) 3.111 0.507   <0.001 2.112 4.110   
.614 0.365 0.591 0.026 0.0026 
Heart Rate [beats/minute] .026 .004 .443 <0.001 .019 .033 1.229 
Sex [Female: 1; Male: 0] -0.471 0.089 -.318 <0.001 -0.647 -0.295 1.275 
Signal Quality (categorical variable) -.364 .104 -.198 0.001 -.569 -.159 1.117 
Body Surface Area [m2] 0.511 0.168 .191 0.003 0.179 0.842 1.386 
Cardiac output [liters/minute] 5 (Constant) 3.561 0.503   <0.001 2.569 4.553   .647 0.405 0.571 0.042 9.670E-05 
Heart Rate [beats/minute] .021 .004 .347 <0.001 .013 .028 1.446 
Sex [Female: 1; Male: 0] -0.365 0.091 -.246 <0.001 -0.544 -0.187 1.397 
Signal Quality (categorical variable) -.379 .101 -.206 <0.001 -.578 -.181 1.119 
Body Surface Area [m2] 0.696 0.169 .261 <0.001 0.363 1.030 1.500 
Age [years] -0.009 0.002 -.242 <0.001 -0.013 -.004 1.387 
Cardiac Index [l.min/m2] 1 
(Constant) 5.313 .214   <0.001 4.891 5.735   
.625 0.387 0.480 0.390 3.163E-25 
Body Surface Area [m2] -1.383 .117 -.625 <0.001 -1.614 -1.152 1.000 
Cardiac Index [l.min/m2] 2 
(Constant) 3.391 .289   <0.001 2.821 3.962   
.739 0.542 0.415 0.155 1.253E-15 Body Surface Area [m
2] -1.082 .107 -.489 <0.001 -1.293 -.871 1.119 
Heart Rate [beats/minute] .020 .002 .418 <0.001 .016 .025 1.119 
Cardiac Index [l.min/m2] 3 
(Constant) 4.135 .294   <0.001 3.556 4.714   
.784 0.608 0.3841 0.067 3.823E-09 
Body Surface Area [m2] -1.389 .111 -.627 <0.001 -1.607 -1.170 1.403 
Heart Rate [beats/minute] .020 .002 .412 <0.001 .016 .025 1.119 
Sex [Female: 1; Male: 0] -.360 .059 -.294 <0.001 -.476 -.245 1.278 
Cardiac Index [l.min/m2] 4 
(Constant) 4.403 .292   <0.001 3.828 4.978   
.801 0.634 0.371 0.026 8.050-05 
Body Surface Area [m2] -1.265 .111 -.571 <0.001 -1.484 -1.045 1.519 
Heart Rate [beats/minute] .017 .002 .340 <0.001 .012 .021 1.315 
Sex [Female: 1; Male: 0] -.289 .059 -.236 <0.001 -.406 -.172 1.401 
Age [years] -.006 .001 -.193 <0.001 -.008 -.003 1.380 
Cardiac Index [l.min/m2] 5 
(Constant) 4.687 .306   <0.001 4.084 5.289   
.808 0.644 0.365 0.012 0.0068 
Body Surface Area [m2] -1.259 .110 -.569 <0.001 -1.476 -1.042 1.520 
Heart Rate [beats/minute] .015 .002 .310 <0.001 .011 .020 1.388 
Sex [Female: 1; Male: 0] -.286 .058 -.234 <0.001 -.402 -.171 1.402 
Age [years] -.006 .001 -.201 <0.001 -.009 -.003 1.385 
Signal Quality (categorical variable) -.131 .048 -.114 0.007 -.226 -.037 1.063 
R: Pearson coefficient. 95%-CI: 95% Confidence Interval. SE: standard error. VIF:variance inflation factor. Stroke volume, cardiac ouptut and index were obtained using the pulse contour analysis (PCA) algorithm. A p value <0.05 (red text) was considered statistically significant. 
 





